The shift towards preventative healthcare and corporate wellness programs is accelerating, fueled by increasing awareness of sleep's impact on chronic diseases and mental health. Regulatory bodies are also encouraging data-driven health interventions. Companies seek non-invasive, scalable solutions to enhance employee well-being and reduce healthcare burdens, while consumers demand personalized health insights from accessible devices. This creates a strong market pull for precise, user-friendly sleep diagnostics.
Achieves higher accuracy in sleep stage estimation by integrating body movement, heart rate, and respiration data to individually identify Awake, NREM, and REM stages.
Enables simple, non-invasive data acquisition, requiring no specialized medical equipment and reducing user burden for daily sleep monitoring.
Enhances determination reliability and robustness by using a unique logic that sets thresholds based on integrated body movement, heart rate, and respiration data.
This patent protects a robust method and device for high-accuracy sleep stage determination using integrated biometric data (body movement, heart rate, respiration). It successfully overcame an initial rejection, indicating a well-defined and stable scope of claims that provides strong defense against future invalidation challenges, offering licensees clear freedom to operate.
This patent primarily covers sleep stage detection. White space exists in developing personalized sleep intervention systems, integrating with smart home environmental controls, or applying the technology for pharmaceutical efficacy testing.
For a company with 1,000 employees, assuming annual personnel costs of ~$33.5M (AI est.), a 0.5% productivity improvement from better sleep could yield ~$167.5K/year (AI est.). Including healthcare cost reductions from early detection of sleep-related issues, total annual savings and value creation could exceed ~$200K (AI est.).
X: Precision and Simplicity
Y: Deployment & Operational Cost Efficiency